Seven Eight Capital LP Has $927,000 Stock Position in agilon health, inc. (NYSE:AGL)

Seven Eight Capital LP lessened its holdings in agilon health, inc. (NYSE:AGL) by 45.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 141,719 shares of the company’s stock after selling 119,507 shares during the quarter. Seven Eight Capital LP’s holdings in agilon health were worth $927,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. J.Safra Asset Management Corp boosted its stake in agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares in the last quarter. Quest Partners LLC acquired a new stake in shares of agilon health in the 4th quarter valued at approximately $45,000. Neo Ivy Capital Management bought a new stake in shares of agilon health during the 4th quarter valued at approximately $47,000. CWM LLC increased its position in agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after purchasing an additional 7,288 shares in the last quarter. Finally, Nisa Investment Advisors LLC bought a new position in agilon health in the 2nd quarter valued at approximately $60,000.

agilon health Price Performance

Shares of AGL opened at $3.52 on Friday. The firm has a market cap of $1.45 billion, a PE ratio of -5.03 and a beta of 0.54. agilon health, inc. has a 52-week low of $3.07 and a 52-week high of $20.37. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. The business’s 50 day moving average price is $5.22 and its two-hundred day moving average price is $5.54.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, meeting the consensus estimate of ($0.07). agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The company had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period last year, the business posted ($0.04) EPS. The firm’s revenue for the quarter was up 38.7% compared to the same quarter last year. On average, equities analysts anticipate that agilon health, inc. will post -0.32 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the stock. Robert W. Baird initiated coverage on shares of agilon health in a report on Thursday, May 30th. They set a “neutral” rating and a $6.00 price target for the company. Baird R W upgraded agilon health to a “hold” rating in a research report on Thursday, May 30th. Truist Financial boosted their price target on agilon health from $6.40 to $6.50 and gave the stock a “hold” rating in a report on Friday, May 24th. Benchmark reiterated a “buy” rating and issued a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Finally, Evercore ISI boosted their target price on shares of agilon health from $5.50 to $7.00 and gave the stock an “in-line” rating in a report on Tuesday, July 9th. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $8.57.

Insider Transactions at agilon health

In other agilon health news, CEO Steven Sell purchased 20,000 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 3.20% of the stock is owned by insiders.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.